P3 Health Partners Inc. Form 8-K Summary
Business Context and Reporting Period
P3 Health Partners Inc. filed a Form 8-K dated July 24, 2023, reporting the results of its 2023 Annual Meeting of Stockholders. The filing is not a quarterly or annual financial report and does not provide operating or financial-period results.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating performance metrics.
Material Changes and Corporate Actions
- Stockholders elected three Class II directors, each to serve until the 2026 annual meeting and until a successor is duly elected and qualified:
- Amir Bacchus, M.D.: 203,298,421 votes for, 39,762,923 withheld, and 4,590,790 broker non-votes.
- Mark Thierer: 203,495,651 votes for, 39,565,693 withheld, and 4,590,790 broker non-votes.
- Lawrence B. Leisure: 195,927,721 votes for, 47,133,623 withheld, and 4,590,790 broker non-votes.
- Stockholders ratified BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
- The auditor appointment received 247,477,842 votes for, 162,838 against, and 11,454 abstentions; there were no broker non-votes.
Outlook, Risks, and Unusual Items
The filing contains no management outlook, risk disclosures, contingencies, or unusual financial items. The Company identified itself as an emerging growth company.
Key Facts for Investors to Verify
- Confirm the election and term status of the three Class II directors.
- Confirm BDO USA, LLP’s appointment for the fiscal year ending December 31, 2023.
- Review the Company’s proxy statement and subsequent filings for governance details, board composition, and any related-party or committee changes.
- Consult the Company’s quarterly and annual reports for financial performance, liquidity, debt, and operating outlook, which are not included in this 8-K.